ABSTRACT
United States regulatory and research agencies may rely upon skin sensitization test data to assess the sensitization hazards associated with dermal exposure to chemicals and products. These data are evaluated to ensure that such substances will not cause unreasonable adverse effects to human health when used appropriately. The US Consumer Product Safety Commission, the US Environmental Protection Agency, the US Food and Drug Administration, the Occupational Safety and Health Administration, the National Institute for Occupational Safety and Health, and the US Department of Defense are member agencies of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). ICCVAM seeks to identify opportunities for the use of non-animal replacements to satisfy these testing needs and requirements. This review identifies the standards, test guidelines, or guidance documents that are applicable to satisfy each of these agency's needs; the current use of animal testing and flexibility for using alternative methodologies; information needed from alternative tests to fulfill the needs for skin sensitization data; and whether data from non-animal alternative approaches are accepted by these US federal agencies.
Subject(s)
Skin Tests/standards , United States Government Agencies , Animal Testing Alternatives , Animals , Humans , United StatesABSTRACT
AIM: The goal of this study was to determine whether bacterial clearance in a rodent model would be impaired upon exposure to gold, silver or silica nanoparticles (NPs). MATERIALS & METHODS: Mice received weekly injections of NPs followed by a challenge of Listeria monocytogenes (LM). On days 3 and 10 after LM injections, the animals were sacrificed and their tissues were collected for elemental analysis, electron microscopy and LM count determination. RESULTS: The untreated and NP-treated animals cleared LM at the same rate suggesting that bioaccumulation of NPs did not increase the animals' susceptibility to bacterial infection. CONCLUSION: The data from this study indicate that the bioaccumulation of NPs does not significantly affect the ability to react to a bacterial challenge.
Subject(s)
Listeria monocytogenes/drug effects , Listeriosis/drug therapy , Nanoparticles/chemistry , Administration, Intravenous , Animals , Cell Survival , Female , Gold/chemistry , Humans , Listeriosis/metabolism , Listeriosis/microbiology , Macrophages/cytology , Macrophages/drug effects , Mice , Mice, Inbred BALB C , Particle Size , RAW 264.7 Cells , Reactive Oxygen Species/metabolism , Silicon Dioxide/chemistry , Silver/chemistry , Surface Properties , Tissue DistributionABSTRACT
BACKGROUND: As nanoparticles (NPs) become more prevalent in the pharmaceutical industry, questions have arisen from both industry and regulatory stakeholders about the long term effects of these materials. This study was designed to evaluate whether gold (10 nm), silver (50 nm), or silica (10 nm) nanoparticles administered intravenously to mice for up to 8 weeks at doses known to be sub-toxic (non-toxic at single acute or repeat dosing levels) and clinically relevant could produce significant bioaccumulation in liver and spleen macrophages. RESULTS: Repeated dosing with gold, silver, and silica nanoparticles did not saturate bioaccumulation in liver or spleen macrophages. While no toxicity was observed with gold and silver nanoparticles throughout the 8 week experiment, some effects including histopathological and serum chemistry changes were observed with silica nanoparticles starting at week 3. No major changes in the splenocyte population were observed during the study for any of the nanoparticles tested. CONCLUSIONS: The clinical impact of these changes is unclear but suggests that the mononuclear phagocytic system is able to handle repeated doses of nanoparticles.
Subject(s)
Gold/toxicity , Liver/drug effects , Macrophages/drug effects , Nanoparticles , Silicon Dioxide/toxicity , Silver/toxicity , Spleen/drug effects , Animals , Biomarkers/blood , Female , Gold/administration & dosage , Gold/metabolism , Injections, Intravenous , Liver/metabolism , Liver/pathology , Macrophages/metabolism , Macrophages/pathology , Metal Nanoparticles , Mice, Inbred BALB C , Risk Assessment , Silicon Dioxide/administration & dosage , Silicon Dioxide/metabolism , Silver/administration & dosage , Silver/metabolism , Spleen/metabolism , Spleen/pathology , Time Factors , Tissue DistributionABSTRACT
The accumulation of durable nanoparticles (NPs) in macrophages following systemic administration is well described. The ultimate biological impact of this accumulation on macrophage function, however, is not fully understood. In this study, nontoxic doses of two durable NPs, SiO2 and Au, at particle sizes of ~10 nm and 300 nm were used to evaluate the effect of bioaccumulation on macrophage function in vitro using RAW 264.7 mouse macrophage-like cells as a model system. Cell proliferation, cell cycle, cytokine production, surface marker activation, and phagocytosis responses were evaluated through a panel of assays using flow cytometry and confocal microscopy. The most dramatic change in RAW 264.7 cell function was a reduction in phagocytosis as monitored by the uptake of Escherichia coli. Cells exposed to both 10 nm Au NPs and 10 nm SiO2 NPs showed ~50% decrease in phagocytosis, while the larger NPs caused a less dramatic reduction. In addition to modifying phagocytosis profiles, 10 nm SiO2 NPs caused changes in proliferation, cell cycle, and cell morphology. Au NPs had no effect on cell cycle, cytokine production, or surface markers and caused interference in phagocytosis in the form of quenching when the assay was performed via flow cytometry. Confocal microscopy analysis was used to minimize this interference and demonstrated that both sizes of Au NPs decreased the phagocytosis of E. coli. Overall, our results demonstrate that Au and SiO2 NP uptake by macrophages can influence macrophage phagocytosis in vitro without altering surface markers and cytokine production in vitro. While the biological impact of these findings remains unclear, our results indicate that bioaccumulation of durable NPs within the macrophages may lead to a suppression of bacterial uptake and possibly impair bactericidal activity.
Subject(s)
Cell Proliferation/drug effects , Gold/chemistry , Macrophages/drug effects , Metal Nanoparticles/chemistry , Phagocytosis/drug effects , Silicon Dioxide/chemistry , Animals , Cell Survival/drug effects , Cytokines/metabolism , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Escherichia coli/metabolism , Macrophages/cytology , Macrophages/metabolism , Mice , Particle Size , RAW 264.7 CellsABSTRACT
BACKGROUND: Cell culture conditions can greatly influence the results of nanoparticle (NP) uptake assays. In this study, 10 nm gold nanoparticles (AuNPs) and RAW 264.7 macrophages were used as a model system, while instrumental neutron activation analysis (NAA) was used as the elemental analysis technique to determine AuNP levels produced by the various culturing conditions. Static plate-based and insert-based culture conditions were compared with a dynamic suspension culture to evaluate the conditions' effect on the rate and extent of AuNP uptake. RESULTS: The results indicate that a dynamic culturing condition allows for the greatest NP uptake (approximately 3-5 times over the adherent conditions), whereas the plate-based assays have the initial highest rate of NP incorporation. CONCLUSIONS: These data highlight the importance of judiciously choosing the assay conditions prior to evaluating NP uptake.
Subject(s)
Gold/pharmacokinetics , Nanoparticles , Animals , Cell Culture Techniques , Cell Proliferation/drug effects , Gold/chemistry , Limit of Detection , Mice , Nanoparticles/chemistry , Neutron Activation Analysis , RAW 264.7 Cells/drug effectsABSTRACT
Previously we found that regulation of eNOS is an important part of the pathogenic process of Drug-induced vascular injury (DIVI) for PDE4i. The aims of the current study were to examine the phosphorylation of eNOS in mesentery versus aorta at known regulatory sites across DIVI-inducing drug classes and to compare changes across species. We found that phosphorylation at S615 in rats was elevated 35-fold 2 hr after the last dose of CI-1044 in mesentery versus 3-fold in aorta. Immunoprecipitation studies revealed that many of the upstream regulators of eNOS activation were associated with eNOS in 1 or more signalosome complexes. Next rats were treated with drugs from 4 other classes known to cause DIVI. Each drug was given alone and in combination with SIN-1 (NO donor) or L-NAME (eNOS inhibitor), and the level of eNOS phosphorylation in mesentery and aorta tissue was correlated with the extent of vascular injury and measured serum nitrite. Drugs or combinations produced altered serum nitrite levels as well as vascular injury score in the mesentery. The results suggested that phosphorylation of S615 may be associated with DIVI activity. Studies with the species-specific A2A adenosine agonist CI-947 in rats versus primates showed a similar pattern.
Subject(s)
Drug-Related Side Effects and Adverse Reactions , Nitric Oxide Synthase Type III/metabolism , Vascular System Injuries/chemically induced , Vascular System Injuries/pathology , Adenosine/administration & dosage , Adenosine/adverse effects , Adenosine/analogs & derivatives , Animals , Aorta/metabolism , Azepines/administration & dosage , Azepines/adverse effects , Dose-Response Relationship, Drug , Male , Niacinamide/administration & dosage , Niacinamide/adverse effects , Niacinamide/analogs & derivatives , Nitric Oxide/blood , Nitric Oxide Synthase Type III/genetics , Nitrites/blood , Phosphorylation , Rats , Rats, Sprague-DawleyABSTRACT
Specialized proresolving mediators are endogenous bioactive lipid molecules that play a fundamental role in the regulation of inflammation and its resolution. Lipoxins and other specialized proresolving mediators have been identified in important immunological tissues including bone marrow, spleen, and blood. Lipoxins regulate functions of the innate immune system including the promotion of monocyte recruitment and increase macrophage phagocytosis of apoptotic neutrophils. A major knowledge gap is whether lipoxins influence adaptive immune cells. Here, we analyzed the actions of lipoxin A4 (LXA4) and its receptor ALX/FPR2 on human and mouse B cells. LXA4 decreased IgM and IgG production on activated human B cells through ALX/FPR2-dependent signaling, which downregulated NF-κB p65 nuclear translocation. LXA4 also inhibited human memory B-cell antibody production and proliferation, but not naïve B-cell function. Lastly, LXA4 decreased antigen-specific antibody production in an OVA immunization mouse model. To our knowledge, this is the first description of the actions of lipoxins on human B cells, demonstrating a link between resolution signals and adaptive immunity. Regulating antibody production is crucial to prevent unwanted inflammation. Harnessing the ability of lipoxins to decrease memory B-cell antibody production can be beneficial to threat inflammatory and autoimmune disorders.
Subject(s)
Adaptive Immunity/immunology , Adaptor Proteins, Signal Transducing/immunology , B-Lymphocytes/immunology , Immunologic Memory/immunology , Lipoxins/immunology , Receptors, Formyl Peptide/immunology , Receptors, Lipoxin/immunology , Animals , Antibodies/immunology , Cell Proliferation , Cells, Cultured , Down-Regulation/immunology , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Inflammation/immunology , Lymphocyte Activation/immunology , Mice , Mice, Inbred C57BL , Protein Transport/immunology , Signal Transduction/immunology , Up-Regulation/immunologyABSTRACT
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily. PPARγ, a ligand-activated transcription factor, has important anti-inflammatory and antiproliferative functions, and it has been associated with diseases including diabetes, scarring, and atherosclerosis, among others. PPARγ is expressed in most bone marrow-derived cells and influences their function. PPARγ ligands can stimulate human B cell differentiation and promote Ab production. A knowledge gap is that the role of PPARγ in B cells under physiological conditions is not known. We developed a new B cell-specific PPARγ (B-PPARγ) knockout mouse and explored the role of PPARγ during both the primary and secondary immune response. In this article, we show that PPARγ deficiency in B cells decreases germinal center B cells and plasma cell development, as well as the levels of circulating Ag-specific Abs during a primary challenge. Inability to generate germinal center B cells and plasma cells is correlated to decreased MHC class II expression and decreased Bcl-6 and Blimp-1 levels. Furthermore, B-PPARγ-deficient mice have an impaired memory response, characterized by low titers of Ag-specific Abs and low numbers of Ag-experienced, Ab-secreting cells. However, B-PPARγ-deficient mice have no differences in B cell population distribution within primary or secondary lymphoid organs during development. This is the first report, to our knowledge, to show that, under physiological conditions, PPARγ expression in B cells is required for an efficient B cell-mediated immune response as it regulates B cell differentiation and Ab production.
Subject(s)
Antibodies/immunology , Antibody Formation/physiology , Antibody Specificity/physiology , Cell Differentiation/immunology , PPAR gamma/immunology , Plasma Cells/immunology , Animals , Antibodies/genetics , Cell Differentiation/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/immunology , Humans , Mice , Mice, Knockout , Organ Specificity , PPAR gamma/genetics , Plasma Cells/cytology , Positive Regulatory Domain I-Binding Factor 1 , Proto-Oncogene Proteins c-bcl-6 , Transcription Factors/genetics , Transcription Factors/immunologyABSTRACT
Worldwide the elderly population is increasing. The elderly show deficiencies in immune function. B lymphocytes are essential elements of the immune system responsible for antibody production. This laboratory previously showed that activated human B cells isolated from young adults express cyclooxygenase-2 (Cox-2) and that Cox-2 is essential for optimal antibody responses. Recent data suggests that Cox-2 expression decreases with age in mouse bone tissue. There is no information regarding Cox-2 expression in B cells from older human subjects. We investigated the expression and activity of Cox-2 in naïve and memory B cells from older people. We show that B cells from older subjects show similar Cox-2 protein expression and activity, antibody production and proliferation compared to younger people. However, we found that activated memory B cells from older people produce higher levels of IL-6 and IL-10 compared to young adults. Therefore, the dysregulated cytokine production could contribute to immune senescence in the elderly.
Subject(s)
Aging/immunology , B-Lymphocyte Subsets/metabolism , Cyclooxygenase 2/metabolism , Interleukin-10/metabolism , Interleukin-6/metabolism , Lymphocyte Activation/immunology , Adolescent , Adult , Aged , Antibodies/blood , Antibodies, Anti-Idiotypic/pharmacology , Antibody Formation/drug effects , Antibody Formation/immunology , Antigens, CD/metabolism , Antigens, CD19/metabolism , Antigens, Differentiation, T-Lymphocyte/metabolism , B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/drug effects , B-Lymphocyte Subsets/immunology , Cell Proliferation/drug effects , Dinoprostone/metabolism , Female , Humans , Lectins, C-Type/metabolism , Lymphocyte Activation/drug effects , Lymphocyte Count , Male , Middle Aged , Oligodeoxyribonucleotides/pharmacology , Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism , Young AdultABSTRACT
Heme-oxygenase-1 (HO-1) is induced in response to oxidative stress and is believed to be a cytoprotective and anti-inflammatory enzyme. It is unknown whether normal or malignant human B-lineage cells express HO-1. 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is an interesting electrophilic lipid mediator able to increase oxidative stress in B cells. Here, we tested normal and malignant human B-lineage cells for their ability to express HO-1 in response to 15d-PGJ(2), as well as the signaling pathways required for HO-1 expression. 15d-PGJ(2) potently induced HO-1 protein expression in normal and malignant B cells. Malignant B cells exhibited a greater induction of HO-1 protein compared to normal B lymphocytes. Using siRNA directed against the transcription factor Nrf2 and B cells isolated from Nrf2-deficient mice, we show that HO-1 induction by 15d-PGJ(2) is dependent on Nrf2. These results show that, compared to normal B lymphocytes, malignant B cells have a greater capacity to increase their HO-1 protein levels in response to 15d-PGJ(2). We speculate that the ability to highly express HO-1 by malignant B cells could confer a survival advantage.
Subject(s)
B-Lymphocytes/metabolism , Heme Oxygenase-1/metabolism , Leukemia, B-Cell/metabolism , NF-E2-Related Factor 2/metabolism , Prostaglandin D2/analogs & derivatives , Animals , B-Lymphocytes/immunology , Cells, Cultured , Gene Expression Regulation, Enzymologic , Humans , Leukemia, B-Cell/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-E2-Related Factor 2/deficiency , NF-E2-Related Factor 2/genetics , Prostaglandin D2/immunology , RNA, Small Interfering/genetics , Transcription, GeneticABSTRACT
Generation of optimal humoral immunity to vaccination is essential to protect against devastating infectious agents such as the variola virus that causes smallpox. Vaccinia virus (VV), employed as a vaccine against smallpox, provides an important model of infection. Herein, we evaluated the importance cyclooxygenase-2 (Cox-2) in immunity to VV using Cox-2 deficient mice and Cox-2 selective inhibitory drugs. The effects of Cox-2 inhibition on antibody responses to live viruses such as vaccinia have not been previously described. Here, we used VV infection in Cox-2 deficient mice and in mice chronically treated with Cox-2 selective inhibitors and show that the frequency of VV-specific B cells was reduced, as well as the production of neutralizing IgG. VV titers were approximately 70 times higher in mice treated with a Cox-2 selective inhibitor. Interestingly, Cox-2 inhibition also reduced the frequency of IFN-gamma producing CD4(+) T helper cells, important for class switching. The significance of these results is that the chronic use of non-steroidal anti-inflammatory drugs (NSAIDs), and other drugs that inhibit Cox-2 activity or expression, blunt the ability of B cells to produce anti-viral antibodies, thereby making vaccines less effective and possibly increasing susceptibility to viral infection. These new findings support an essential role for Cox-2 in regulating humoral immunity.
Subject(s)
Antibodies, Viral/immunology , B-Lymphocytes/immunology , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2/immunology , Immunity, Humoral/drug effects , Immunoglobulin G/immunology , Vaccinia virus/immunology , Vaccinia/immunology , Animals , Cyclooxygenase 2/genetics , Immunity, Humoral/genetics , Immunity, Humoral/immunology , Mice , Mice, Knockout , T-Lymphocytes, Helper-Inducer/immunology , Vaccinia/geneticsABSTRACT
The widely used non-steroidal anti-inflammatory drugs (NSAIDs) function mainly through inhibition of cyclooxygenases 1 and 2 (Cox-1 and Cox-2). Unlike Cox-1, Cox-2 is considered an inducible and pro-inflammatory enzyme. We previously reported that Cox-2 is upregulated in activated human B lymphocytes and using Cox-2 selective inhibitors that Cox-2 is required for optimal antibody synthesis. It is not known whether commonly used non-prescription and non-Cox-2 selective drugs also influence antibody synthesis. Herein, we tested a variety of Cox-1/Cox-2 non-selective NSAIDs, namely ibuprofen, tylenol, aspirin and naproxen and report that they blunt IgM and IgG synthesis in stimulated human peripheral blood mononuclear cells (PBMC). Ibuprofen had its most profound effects in inhibiting human PBMCs and purified B lymphocyte IgM and IgG synthesis when administered in the first few days after activation. As shown by viability assays, ibuprofen did not kill B cells. The implications of this research are that the use of widely available NSAIDs after infection or vaccination may lower host defense. This may be especially true for the elderly who respond poorly to vaccines and heavily use NSAIDs.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antibody Formation/drug effects , B-Lymphocytes/drug effects , Cyclooxygenase Inhibitors/pharmacology , Ibuprofen/pharmacology , Animals , Antibody Formation/immunology , B-Lymphocytes/immunology , Cell Survival/drug effects , Cell Survival/immunology , Cyclooxygenase 1/drug effects , Cyclooxygenase 1/metabolism , Cyclooxygenase 2/drug effects , Cyclooxygenase 2/metabolism , Humans , Immunoglobulin G/biosynthesis , Immunoglobulin M/biosynthesis , Mice , Mice, Knockout , Pyrazoles/pharmacologyABSTRACT
The transcriptional repressor E2F4 is important for cell cycle exit and terminal differentiation in epithelial cells, neuronal cells and adipocytes but its role in T lymphocytes proliferation and memory formation is not known. Herein, we investigated the function of E2F4 protein for the formation of functional murine memory T cells. Murine transgenic CD8+ T cells were infected in vitro with lentivirus vector expressing a shRNA targeted against E2F4 followed by in vitro stimulation with SIINFEKL antigenic peptide. For in vivo assays, transduced cells were injected into congenic mice which were then infected with HSV-OVA. The primary response, memory formation and secondary stimulation were determined for CD8+ lentivirus transduced cells. In the absence of E2F4 cell cycle repressor, activated CD8+ T cells underwent intensive proliferation in vitro and in vivo. These cells had the ability to differentiate into memory cells in vivo, but they were defective in recall proliferation. We show that transient suppression of E2F4 during CD8+ T cell priming enhances primary proliferation and has a negative effect on secondary stimulation. These findings demonstrate that the cell cycle repressor E2F4 is essential for the formation of functional memory T cells. A decrease in CD8+ T-lymphocyte compartment would diminish our capacity to control viral infections.
Subject(s)
CD8-Positive T-Lymphocytes/immunology , E2F4 Transcription Factor/immunology , Immunologic Memory , Animals , CD8-Positive T-Lymphocytes/metabolism , Cell Proliferation , Cross-Priming , E2F4 Transcription Factor/genetics , Gene Knockdown Techniques , Mice , Mice, Inbred C57BL , Mice, Transgenic , Ovalbumin/immunology , Peptide Fragments/immunologyABSTRACT
The E2F4 protein is involved in gene repression and cell cycle exit, and also has poorly understood effects in differentiation. We analyzed the impact of E2F4 deficiency on early steps in mouse hematopoietic development, and found defects in early hematopoietic progenitor cells that were propagated through common lymphoid precursors to the B and T lineages. In contrast, the defects in erythromyeloid precursor cells were self-correcting over time. This suggests that E2F4 is important in early stages of commitment to the lymphoid lineage. The E2F4-deficient progenitor cells showed reduced expression of several key lymphoid-lineage genes, and overexpression of two erythromyeloid lineage genes. However, we did not detect effects on cell proliferation. These findings emphasize the significance of E2F4 in controlling gene expression and cell fate.
Subject(s)
Cell Differentiation/immunology , Cell Lineage/immunology , E2F2 Transcription Factor/physiology , Gene Expression Regulation/immunology , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Lymphocytes/cytology , Lymphocytes/metabolism , Animals , Cell Cycle Proteins/genetics , Cell Cycle Proteins/physiology , Cell Differentiation/genetics , Cell Lineage/genetics , E2F2 Transcription Factor/deficiency , E2F2 Transcription Factor/genetics , Female , Fetus , Ikaros Transcription Factor/deficiency , Ikaros Transcription Factor/genetics , Liver/cytology , Liver/immunology , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Myeloid Cells/cytology , Myeloid Cells/immunology , Myeloid Cells/metabolismABSTRACT
Brassinosteroids (BRs) are biosynthesized from campesterol via several cytochrome P450 (P450)-catalyzed oxidative reactions. We report the functional characterization of two BR-biosynthetic P450s from Arabidopsis thaliana: CYP90C1/ROTUNDIFOLIA3 and CYP90D1. The cyp90c1 cyp90d1 double mutant exhibits the characteristic BR-deficient dwarf phenotype, although the individual mutants do not display this phenotype. These data suggest redundant roles for these P450s. In vitro biochemical assays using insect cell-expressed proteins revealed that both CYP90C1 and CYP90D1 catalyze C-23 hydroxylation of various 22-hydroxylated BRs with markedly different catalytic efficiencies. Both enzymes preferentially convert 3-epi-6-deoxocathasterone, (22S,24R)-22-hydroxy-5alpha-ergostan-3-one, and (22S,24R)-22-hydroxyergost-4-en-3-one to 23-hydroxylated products, whereas they are less active on 6-deoxocathasterone. Likewise, cyp90c1 cyp90d1 plants were deficient in 23-hydroxylated BRs, and in feeding experiments using exogenously supplied intermediates, only 23-hydroxylated BRs rescued the growth deficiency of the cyp90c1 cyp90d1 mutant. Thus, CYP90C1 and CYP90D1 are redundant BR C-23 hydroxylases. Moreover, their preferential substrates are present in the endogenous Arabidopsis BR pool. Based on these results, we propose C-23 hydroxylation shortcuts that bypass campestanol, 6-deoxocathasterone, and 6-deoxoteasterone and lead directly from (22S,24R)-22-hydroxy-5alpha-ergostan-3-one and 3-epi-6-deoxocathasterone to 3-dehydro-6-deoxoteasterone and 6-deoxotyphasterol.
Subject(s)
Arabidopsis Proteins/metabolism , Arabidopsis/enzymology , Carbon/metabolism , Cytochrome P-450 Enzyme System/metabolism , Phytosterols/biosynthesis , Animals , Arabidopsis/drug effects , Arabidopsis Proteins/genetics , Catalysis/drug effects , Cotyledon/drug effects , Cotyledon/enzymology , Cytochrome P-450 Enzyme System/deficiency , Cytochrome P-450 Enzyme System/genetics , Exons/genetics , Gas Chromatography-Mass Spectrometry , Gene Expression/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Plant/drug effects , Hydroxylation/drug effects , Hypocotyl/drug effects , Hypocotyl/enzymology , Insecta/cytology , Introns/genetics , Kinetics , Mutation/genetics , Phenotype , Phytosterols/analysis , Phytosterols/chemistry , Phytosterols/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Substrate SpecificityABSTRACT
Plant steroid hormones, brassinosteroids (BRs), are essential for normal photomorphogenesis. However, the mechanism by which light controls physiological functions via BRs is not well understood. Using transgenic plants carrying promoter-luciferase reporter gene fusions, we show that in Arabidopsis (Arabidopsis thaliana) the BR-biosynthetic CPD and CYP85A2 genes are under diurnal regulation. The complex diurnal expression profile of CPD is determined by dual, light-dependent, and circadian control. The severely decreased expression level of CPD in phytochrome-deficient background and the red light-specific induction in wild-type plants suggest that light regulation of CPD is primarily mediated by phytochrome signaling. The diurnal rhythmicity of CPD expression is maintained in brassinosteroid insensitive 1 transgenic seedlings, indicating that its transcriptional control is independent of hormonal feedback regulation. Diurnal changes in the expression of CPD and CYP85A2 are accompanied by changes of the endogenous BR content during the day, leading to brassinolide accumulation at the middle of the light phase. We also show that CPD expression is repressed in extended darkness in a BR feedback-dependent manner. In the dark the level of the bioactive hormone did not increase; therefore, our data strongly suggest that light also influences the sensitivity of plants to BRs.
Subject(s)
Arabidopsis Proteins/genetics , Arabidopsis/genetics , Circadian Rhythm , Cytochrome P-450 Enzyme System/genetics , Gene Expression Regulation, Plant , Steroid Hydroxylases/genetics , Arabidopsis/enzymology , Arabidopsis Proteins/metabolism , Cytochrome P-450 Enzyme System/metabolism , Feedback, Physiological , Genes, Reporter , Light , Luciferases/genetics , Luciferases/metabolism , Phytochrome/genetics , Phytochrome/metabolism , Promoter Regions, Genetic , Recombinant Fusion Proteins/metabolism , Signal Transduction , Steroid Hydroxylases/metabolismABSTRACT
Cytochrome P450 enzymes of the closely related CYP90 and CYP85 families catalyze essential oxidative reactions in the biosynthesis of brassinosteroid (BR) hormones. Arabidopsis CYP90B1/DWF4 and CYP90A1/CPD are responsible for respective C-22 and C-23 hydroxylation of the steroid side chain and CYP85A1 catalyzes C-6 oxidation of 6-deoxo intermediates, whereas the functions of CYP90C1/ROT3, CYP90D1, and CYP85A2 are still unknown. Semiquantitative reverse transcriptase-polymerase chain reaction analyses show that transcript levels of CYP85 and CYP90 genes are down-regulated by brassinolide, the end product of the BR biosynthesis pathway. Feedback control of the CYP90C1, CYP90D1, and CYP85A2 genes by brassinolide suggests that the corresponding enzymes might also participate in BR synthesis. CYP85 and CYP90 mRNAs show strong and transient accumulation during the 1st week of seedling development, as well as characteristic organ-specific distribution. Transcripts of CYP90A1 and CYP85A2 are preferentially represented in shoots and CYP90C1, CYP90D1, and CYP85A1 mRNAs are more abundant in roots, whereas CYP90B1 is ubiquitously expressed. Remarkably, the spatial pattern of CYP90A1 expression is maintained in the BR-insensitive cbb2 mutant, indicating the independence of organ-specific and BR-dependent regulation. Quantitative gas chromatography-mass spectrometry analysis of endogenous BRs in shoots and roots of Arabidopsis, pea (Pisum sativum), and tomato (Lycopersicon esculentum) reveal similar partitioning patterns of BR intermediates in these species. Inverse correlation between CYP90A1/CPD transcript levels and the amounts of the CYP90A1 substrate 6-deoxocathasterone in shoots and roots suggests that transcriptional regulation plays an important role in controlling BR biosynthesis.
Subject(s)
Arabidopsis Proteins , Arabidopsis/genetics , Cholestanols/metabolism , Cytochrome P-450 Enzyme System/genetics , Steroids, Heterocyclic/metabolism , Arabidopsis/enzymology , Arabidopsis/growth & development , Brassinosteroids , Cholestanols/chemistry , Cytochrome P-450 Enzyme System/metabolism , Evolution, Molecular , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Plant , Germination/genetics , Solanum lycopersicum/genetics , Solanum lycopersicum/metabolism , Pisum sativum/genetics , Pisum sativum/metabolism , Phylogeny , Plant Roots/genetics , Plant Roots/metabolism , Plant Shoots/genetics , Plant Shoots/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Seeds/genetics , Seeds/growth & development , Seeds/metabolism , Steroid Hydroxylases/genetics , Steroid Hydroxylases/metabolism , Steroids, Heterocyclic/chemistry , Transcription, GeneticABSTRACT
Although many important aspects of plant development are controlled by brassinosteroids (BRs), the early molecular events of their hormonal action are largely unknown. Using a differential-display RT-PCR screen designed to detect early response transcripts, those regulated by BR treatment in the absence of de novo protein synthesis, we identified an Arabidopsis thaliana (L.) Heynh. gene (designated BRH1) that encodes a novel RING finger protein. As deduced from a complete cDNA clone, the 170-amino-acid sequence of BRH1 forms an N-terminal hydrophobic domain and a C-terminal RING-H2 signature. In wild-type Arabidopsis, the level of the BRH1 transcript was rapidly down-regulated by brassinolide, but this effect was abolished in a BR-insensitive mutant deficient in the BRI1 receptor. BRH1 mRNA abundance was not influenced by other phytohormones, but the pathogen elicitor chitin induced a rapid and transient accumulation of the transcript. Antisense expression of BRH1 resulted in transgenic Arabidopsis plants with thicker inflorescence stems and altered leaf morphology, whereas in sense overexpression lines no phenotypic effect could be observed. Considering the potential of the RING proteins to participate in regulatory protein complexes, BR-dependent expression of BRH1 may suggest its involvement in later hormonal effects.